Modeling HIV-1 Within-Host Dynamics After Passive Infusion of the Broadly Neutralizing Antibody VRC01

VRC01 is a broadly neutralizing antibody that targets the CD4 binding site of HIV-1 gp120. Passive administration of VRC01 in humans has assessed the safety and the effect on plasma viremia of this monoclonal antibody (mAb) in a phase 1 clinical trial. After VRC01 infusion, the plasma viral load in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardozo-Ojeda, E. Fabian, Perelson, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438300/
https://www.ncbi.nlm.nih.gov/pubmed/34531859
http://dx.doi.org/10.3389/fimmu.2021.710012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438300/
https://www.ncbi.nlm.nih.gov/pubmed/34531859
http://dx.doi.org/10.3389/fimmu.2021.710012

Ejemplares similares